Ayala Pharmaceuticals Announces Closing of Initial Public Offering

Ayala is an Arc Ventures portfolio company since 2018 . The official press release can be found on the company's website. REHOVOT, Israel & WILMINGTON, Del., May 12, 2020 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and…

Vayyar Imaging Announces $109 Million Series D Financing led by Koch Disruptive Technologies

Vayyar Imaging today announced it closed a $109 million Series D financing round led by Koch Disruptive Technologies (Koch), with Regal Four and all existing investors including Battery Ventures, Bessemer Ventures, ICV, ITI, WRVI Capital, Claltech, bringing the total capital raised to-date to $188 million USD.